Riffyn selected as "Cool Vendor R&D 2017" by Gartner Research

Riffyn selected as "Cool Vendor R&D 2017" by Gartner Research
"This year’s Cool Vendors remind me a bit of André 3000’s early years.  The vendors are new and a bit different.  They are all providing “first time” user experiences and are actively fusing new technology with R&D and laboratory business processes. We see strong elements of IoT and AI solving the complexities in scientific R&D. They all do this while helping usher in this new digital era for R&D."

Alastair Dant Showcases Riffyn's Advanced Visual Tools for R&D at PLOTCON (video)

R & D labs often seek to define and improve production processes. While a well-written protocol spells out a process like a favorite recipe, few standards exist for exchanging process designs and associated experimental data in a more structured fashion. This talk showcases Riffyn's web-based tools for collaborative process design and experimental analysis. 

Riffyn CEO - Tim Gardner - interviewed by Karl Schmieder on biotechnology R&D

Value tends to accrue to people and organizations that can reduce uncertainty.

The place where you can do magic is where you clear the cloud of uncertainty and turn that into something usable. That’s why data scientists are in demand and hold such a powerful role, because they have the potential to reduce uncertainty.

People make bad decisions because they have inadequate information to make good decisions.

I started Riffyn to solve this with computer aided design (CAD), statistical data and an analytics approach to science experimentation.

Riffyn highlighted in the Wall Street Journal

Riffyn was mentioned in a front page article in the WSJ - solving the breakdown in biomedical research.

"Some companies also have stepped into the gap...Riffyn in Oakland, Calif., is another specialized firm in this niche, with software that helps scientists to map out their experiments, manage scattered data sets, pull it all together for analysis and share it with colleagues."

Riffyn and Novozymes Join Forces to Accelerate the Digital Future of Scientific Research

During the SynBioBeta SF conference last October, Riffyn announced the launch of its cloud-based research process design software. The company’s mission to change the pace of research and development through software innovation has now reached new speeds through a key partnership with Novozymes, the largest provider of enzyme and microbial technologies worldwide. The industrial giant will deploy and develop Riffyn’s software, implementing it progressively across Novozymes’ 1000-person global R&D organization to support product development.

Synbiobeta: Confronting the Problem of Knowledge Mismanagement in Life Science R&D

An article by Synbiobeta delves into the issues of data fragmentation, data analysis and tech transfer in life sciences R&D - with interviews of Chris Stevens, the Director of Strategy, Operations and Planning at GSK, and with Tim Gardner, Riffyn's CEO.  From the post:

Today, more resources than ever before are being channeled into life sciences R&D. In recent years, annual worldwide industrial life science R&D spending has exceeded $160 billion and is expected to continue to grow, with government and nonprofit spending on life sciences adding another $60-70B annually to this total.  But, contrary to expectations, the influx of support doesn’t mean that researchers’ jobs are getting any easier—and in fact, in some ways they are getting much harder. Read more at synbiobeta.com.

Riffyn sponsors ResourceMiner, an open science project with PLOS and Mozilla Science Lab

Resource Miner is an open project to develop a natural language processing toolkit for extracting controlled vocabularies (ontologies) of research resources used in the scientific literature, and organizing them into an associative knowledge graph. Riffyn has sponsored this project in collaboration with PLOS and Mozilla Science Lab. The Mozilla Science Lab helps a global network of researchers, tool developers, librarians and publishers collaborate to further science on the web. Find out more and contribute to the ResourceMiner project here.


After having spent time in a lab, one problem that strikes you is how archaic they are in their methods of operation. Adapting to new technologies and workflow habits is not something that science has embraced in that past. Thankfully there are others that feel the same way and are doing something to change this, such as Riffyn.

O'Reilly Radar Podcast: Tim Gardner on the synthetic biology landscape, lab automation, and the problem of reproducibility.

Jenn Webb from O'Reilly Radar interviews Riffyn Founder/CEO Tim Gardner, touching on regulatory issues around synthetic biology, and also Riffyn's vision for improving research reproducibility through the application of the quality approaches that have transformed manufacturing.